ARF, a tumor suppressor [42], can be induced by sustained mitogenic stimulation and plays a key role in activating p53 independently and controlling the stability of p53 through interaction with HDM2 [43], an important regulator of p53. The gene discussed is CDKN2A; the disease is neoplasm.